Michael Palucki
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Palucki.
Tetrahedron Letters | 1995
Michael Palucki; Gregory J. McCormick; Eric N. Jacobsen
Abstract The enantioselective epoxidation of olefins catalyzed by (salen)Mn(III) complexes can be effected under anhydrous conditions with a variety of primary oxidant systems. The combination of m -CPBA and NMO is particularly reactive, allowing for epoxidation reactions to be carried out at −78 °C. Under these low temperature conditions, a variety of unfunctionalized olefins undergo epoxidation with a significant increase in enantioselectivity relative to reaction using aqueous bleach.
Journal of Organic Chemistry | 2010
Francis Gosselin; Britton Ra; Ian W. Davies; Dolman Sj; Danny Gauvreau; Hoerrner Rs; Gregory Hughes; Jacob Janey; Stephen Lau; Carmela Molinaro; Nadeau C; Paul O'shea; Michael Palucki; Rick R. Sidler
Practical, chromatography-free syntheses of 5-lipoxygenase inhibitor MK-0633 p-toluenesulfonate (1) are described. The first route used an asymmetric zincate addition to ethyl 2,2,2-trifluoropyruvate followed by 1,3,4-oxadiazole formation and reductive amination as key steps. An improved second route features an inexpensive diastereomeric salt resolution of vinyl hydroxy-acid 22 followed by a robust end-game featuring a through-process hydrazide acylation/1,3,4-oxadiazole ring closure/salt formation sequence to afford MK-0633 p-toluenesulfonate (1).
Journal of Organic Chemistry | 2009
Carmela Molinaro; Danny Gauvreau; Gregory Hughes; Stephen Lau; Sophie Lauzon; Remy Angelaud; Paul D. O’Shea; Jacob Janey; Michael Palucki; Scott R. Hoerrner; Conrad E. Raab; Rick R. Sidler; Michel Belley; Yongxin Han
A practical large-scale chromatography-free synthesis of EP4 antagonist MF-310, a potential new treatment for chronic inflammation, is presented. The synthetic route provided MF-310 as its sodium salt in 10 steps and 17% overall yield from commercially available pyridine dicarboxylate 7. The key features of this sequence include a unique regioselective reduction of succinimide 2 controlled by the electronic properties of a remote pyridine ring, preparation of cyclopropane carboxylic acid 3 via a Corey-Chaykovsky cyclopropanation, and a short synthesis of sulfonamide 5.
Journal of Organic Chemistry | 2008
Jacob Janey; Charles J. Orella; Eugenia Njolito; Jenny M. Baxter; Jonathan Rosen; Michael Palucki; Rick R. Sidler; Wenjie Li; Jason J. Kowal; Ian W. Davies
An expedient, five step synthesis of caprolactam 1 is reported starting from natural L-homoserine. The key step is a chemoselective reductive cyclization of alpha,beta-unsaturated nitrile 10 mediated by Raney-Co type metals. This hydrogenation is extensively investigated in order to account for the observed product distribution and yields.
Journal of the American Chemical Society | 1998
Michael Palucki; Nathaniel S. Finney; Paul J. Pospisil; Mehmet L. Guler; Toyohisa Ishida; Eric N. Jacobsen
Journal of the American Chemical Society | 1994
Michael Palucki; Paul J. Pospisil; Wei Zhang; Eric N. Jacobsen
Angewandte Chemie | 1997
Nathaniel S. Finney; Paul J. Pospisil; Sukbok Chang; Michael Palucki; Reed G. Konsler; Karl B. Hansen; Eric N. Jacobsen
Organic Process Research & Development | 2005
Karl B. Hansen; Jaume Balsells; Spencer D. Dreher; Yi Hsiao; Michele Kubryk; Michael Palucki; Nelo R. Rivera; Dietrich Steinhuebel; Joseph D. Armstrong; David Askin; Edward J. J. Grabowski
Organic Process Research & Development | 2007
Chaoxian Cai; John Chung; J. Christopher McWilliams; Yongkui Sun; C. Scott Shultz; Michael Palucki
Angewandte Chemie | 1997
Nathaniel S. Finney; Paul J. Pospisil; Sukbok Chang; Michael Palucki; Reed G. Konsler; Karl B. Hansen; Eric N. Jacobsen